Drug Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Conjunctivitis Therapy
Studies from Cedars-Sinai Medical Center, Division of Ophthalmology describe new findings in conjunctivitis therapy
March 2nd, 2007
Research findings, "A case of vancomycin-resistant enterococcus conjunctivitis and its clinically successful topical treatment," are discussed in a new report. In this recently published article, scientists in the United States conducted a study "To describe what is, to our knowledge, the first documented case of vancomycin-resistant enterococcus (VRE) conjunctivitis and its successful topical treatment. A 77-year-old white man with end-stage multiple myeloma was hospitalized for congestive heart failure and pneumonia." "During hospitalization, the patient developed conjunctivitis. Cultures of the eye were directly plated into several media. The bacterium was tested for...
Source: Drug Week (2007-03-02)
|
